MedGen, Inc. is a MedTech and Lifesciences Company. The Company operates in Four Segments, including Biomedical, Healthcare, Precision Medicine and Pharmaceutical. MedGen Portfolio Companies, Divisions and Subsidiaries offers a range of Products, Solutions and Services for Sale and Licensing. The First Subsidiary emb Ded Advanced Technologies, is Additive Manufacturing the Micro amp Nanoscale with Initial Focus on Biotechnology Utilizing D Bioprinting Combining its Patented Process and Apparatus to Produce Consumable Materials and Products that Mimic the Natural Shape of Tissues in the Human Body. The Second Subsidiary OASIC/ emb Ded Biomed, will leverage its Current Patents to Produce Artificial Human Organs Extracorporeal using Biomedical Polyurethanes with a Blood Compatible Scaffold. Application Liver Assist Device, Bridging the Gap until Donor Organ is available. Reducing the amount of Bedside Equipment/ Apparatus and No Need to Separate Plasma Blood Compatible Flow Through Scaffold. Application Drug Development/ Testing. Reducing FDA Rejection Increasing New Drug Approvals by Testing Liver Toxicity Levels before Human Trials. More Efficient than Current Biomarker Testing Direct Test with Direct Results. Other Divisions and Products Include: . Medical Device Coatings. . Smart Bandages. . eTextiles. . Energy Micro Fuel Cells . Follow MedGen on Twitter IncMedgen
Quote | MedGen Inc (OTCMKTS:MDIN)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 40,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | MedGen Inc (OTCMKTS:MDIN)
Medgen ( OTCPK:MDIN ) has entered into a Letter of Intent to acquire 9430075 Canada operating as Magnifind.ca. More news on: MedGen, Inc., Merger & acquisition news, Read more ...
Medgen, Inc. (OTC: MDIN) has entered into a Letter of Intent to acquire 9430075 Canada Ltd. operating as Magnifind.ca (“Magnifind”) based in Winnipeg, MB. This acquisition, which is expected to be completed upon Magnifind US GAAP Audit being finished, puts Medgen squarely in...
Message Board Posts | MedGen Inc (OTCMKTS:MDIN)
Subject | By | Source | When |
---|---|---|---|
DIRECT LINKS??? | pdgood | investorshub | 04/20/2023 3:59:44 PM |
MedGen been dirty 4 a long time | pdgood | investorshub | 04/18/2023 7:18:33 PM |
Sounds like a plan. Going to be | Werbe | investorshub | 04/18/2023 6:29:24 PM |
Canadian CEO is still MIA. | pdgood | investorshub | 04/18/2023 5:23:34 PM |
WAS THE NIR GROUP INVOLVED? | pdgood | investorshub | 04/17/2023 5:48:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Medgen, Inc. (OTC: MDIN) has entered into a Letter of Intent to acquire 9430075 Canada Ltd. operating as Magnifind.ca (“Magnifind”) based in Winnipeg, MB. This acquisition, which is expected to be completed upon Magnifind US GAAP Audit being finished, puts Medgen squarely in...